Carcinoma  >>  epirubicin  >>  Phase 3
Welcome,         Profile    Billing    Logout  

13 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
epirubicin / Generic mfg.
NCT00140075: Adjuvant Epirubicin/Cytoxan Followed By A Taxane VS. Epirubicin/Taxane As Treatment For Node-Positive Breast Cancer

Completed
3
606
US
Epirubicin with Cyclophosphamide, followed by a Taxane, Epirubicin, ellence,, Epirubicin with a Taxane
Pfizer
Adenocarcinoma
08/06
08/06
NCT00201396: A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma

Completed
3
480
RoW
CCRT, Mitomycin C,Epirubicin,Cisplatin,5-Fluorouracil,Leucovorin
National Health Research Institutes, Taiwan, National Taiwan University Hospital, Tri-Service General Hospital, Chang Gung Memorial Hospital, China Medical University Hospital, Chung Shan Medical University, Changhua Christian Hospital, Chi Mei Medical Hospital, Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung Veterans General Hospital., Taipei Veterans General Hospital, Taiwan
Nasopharyngeal Carcinoma
08/09
12/11
NCT00005583: Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer

Completed
3
400
Europe, RoW
cisplatin, doxorubicin hydrochloride, epirubicin hydrochloride, adjuvant therapy, conventional surgery, radiation therapy
Nordic Society of Gynaecological Oncology - Clinical Trials Unit, European Organisation for Research and Treatment of Cancer - EORTC
Endometrial Cancer
 
07/10
NCT00658580: Randomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung Cancer

Completed
3
361
Europe
Cisplatin + etoposide, Epirubicin + ifosfamide + etoposide
European Lung Cancer Working Party
Small Cell Lung Carcinoma, Extensive Disease
12/13
02/15
NCT01053390: New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma

Completed
3
216
RoW
Somatostatin, epirubicin, cisplatin, LV（Leucovorin）、 5-FU（5-Fluorouracil）
Shanghai Jiao Tong University School of Medicine, Xuanwu Hospital, Beijing, Capital Medical University, Peking University First Hospital, Tianjin Medical University Cancer Institute and Hospital, The First Affiliated Hospital of Dalian Medical University, China Medical University, China, The first clinical college of harbin medical university, The Second Affiliated Hospital of Harbin Medical University, Shengjing Hospital, Jilin University, The people's hospital of Heilongjiang province, Eastern Hepatobiliary Surgery Hospital, Shanghai Changzheng Hospital, Shandong Provincial Hospital, Qilu Hospital of Shandong University, Air Force Military Medical University, China, Tang-Du Hospital, Qinghai People's Hospital, Affiliated Hospital of Qinghai University, First Affiliated Hospital of Chongqing Medical University, Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, First People's Hospital of Kunming, Lanzhou university second hospital, Xi'an Central Hospital, The first people's hospital of Guiyang, Southwest Hospital, China, The First Affiliated Hospital of Kunming Medical College
Gallbladder Neoplasms
12/13
12/13
ITACA-S2, NCT01989858 / 2010-021052-25: (Intergroup Trial in Adjuvant Chemotherapy for Adenocarcinoma of the Stomach)

Terminated
3
1180
Europe
peri-operative cht, post-operative CHT, peri-operative cht + post-operative cht-rtx, post-operative cht + post-operative cht-rtx
Mario Negri Institute for Pharmacological Research
Gastric Adenocarcinoma
12/13
12/13
NCT02445209: Comparison of Efficacy and Frequency of Adverse Events of 1st Line Palliative Chemotherapy EOX and mDCF Regimens in Advanced HER2-negative Gastric Carcinoma

Completed
3
56
Europe
EOX, mDCF
Jagiellonian University
HER2 Negative Gastric Cancer
02/14
02/14
NCT01327521: Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma

Withdrawn
3
0
US
CyberKnife, CK, TACE, Transcatheter arterial chemoembolization, CT Contrast, contrast dye, doxorubicin, Adriamycin, hydroxydaunorubicin, Epirubicin, Ellence, Pharmorubicin, Epirubicin Ebewe, 5-fluorouracil, 5-FU, f5U, Adrucil, Carac, Efudix, Efudex, Fluoroplex, Mitomycin C, Mutamycin, MTC, Gemcitabine, Gemzar, Cisplatin, cisplatinum, cis-diamminedichloroplatinum(II), CDDP, Platinol, Platinol-AQ, SMANCS, styrene maleic acid neocarzinostatin, poppyseed oil
Albert Koong, Accuray Incorporated
Carcinoma, Hepatocellular
02/14
 
RILOMET-1, NCT01697072 / 2011-004923-11: First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma

Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Checkmark ASCO 2013
May 2013 - May 2013: ASCO 2013
Terminated
3
609
US, Canada, Europe, RoW
Rilotumumab, AMG102, Placebo, sterile protein-free solution, Epirubicin, Ellence, Pharmorubicin PFS, Pharmorubicin RDF, Cisplatin, Platinol, Platinol-AQ, Capecitabine, Xeloda
Amgen
Gastric Cancer
11/14
08/15
GeparOcto, NCT02125344 / 2014-000619-14: A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer

Completed
3
961
Europe
non-pegylated liposomal doxorubicin, Myocet, Carboplatin, Carbomedac, Paclitaxel, var., Epirubicin, Farmorubicin, Cyclophosphamide, Endoxan, Pertuzumab, Perjeta, Trastuzumab, Herceptin, Ferric carboxymaltose, Ferinject
German Breast Group, Amgen, Roche Pharma AG, Teva Pharmaceuticals USA, Vifor Pharma
Tubular Breast Cancer Stage II, Tubular Breast Cancer Stage III, Mucinous Breast Cancer Stage II, Breast Cancer Female NOS, Invasive Ductal Breast Cancer, HER2 Positive Breast Cancer, Inflammatory Breast Cancer
11/16
01/17
QUINTETT, NCT00907543: Quality of Life in Neoadjuvant Versus Adjuvant Therapy of Esophageal Cancer Treatment Trial

Completed
3
96
Canada
Preoperative treatment of chemotherapy and radiation, Postoperative treatment of chemotherapy and radiation
Richard Malthaner
Esophageal Neoplasms
12/18
12/18
NCT02363400: A Phase III Trial in NPC With Post-radiation Detectable Plasma EBV DNA

Enrolling by invitation
3
147
RoW
MEP, epirubicin, cisplatin, oral Tegafur-uracil, mitomycin-C
National Health Research Institutes, Taiwan, National Taiwan University Hospital, Mackay Memorial Hospital, China Medical University Hospital, National Cheng-Kung University Hospital, Kaohsiung Veterans General Hospital., Taichung Veterans General Hospital
Nasopharyngeal Carcinoma
12/19
12/22
NCT01204437 / 2008-003995-23: Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast

Checkmark EBCC 2014
Mar 2014 - Mar 2014: EBCC 2014
Completed
2/3
400
Europe
Epirubicin, Cyclophosphamide, Cyclophosphamide, Methotrexate, 5 FU, Capecitabine, Nab-Paclitaxel
German Breast Group
Breast Cancer
01/14
01/14

Download Options